What Traditional Chinese Herbal Formulations Are Used to Treat Vitiligo?
Traditional Chinese Medicine (TCM) has long been used as an adjunctive approach in the management of vitiligo—a chronic, autoimmune-mediated depigmenting disorder characterized by progressive loss of
Traditional Chinese Medicine (TCM) has long been used as an adjunctive approach in the management of vitiligo—a chronic, autoimmune-mediated depigmenting disorder characterized by progressive loss of melanocytes and subsequent well-demarcated, hypopigmented or achromic macules and patches. While modern dermatology emphasizes phototherapy, topical corticosteroids, calcineurin inhibitors, and emerging biologics, many patients seek complementary strategies—including standardized herbal formulations—often for perceived safety, holistic benefits, or cultural preference.
Several TCM preparations have undergone clinical evaluation for vitiligo, with varying levels of evidence. One of the most widely studied is Bai Dian Feng Jiao Nang (Vitiligo Capsule), a proprietary formula containing Psoralea corylifolia (buguzhi), Rehmannia glutinosa (shu di huang), Achyranthes bidentata (niu xi), and Salvia miltiorrhiza (dan shen). Its proposed mechanisms include melanocyte stimulation via psoralen-induced photoactivation, antioxidant activity, and modulation of Th17/Treg immune balance. Randomized controlled trials conducted in China report higher repigmentation rates when combined with narrowband UVB compared to phototherapy alone—though methodological limitations, including small sample sizes and inconsistent outcome measures, warrant cautious interpretation.
Another commonly prescribed formulation is Qubai Baidian Pian (Depigmentation-Removing Vitiligo Tablets), which includes Fructus Tribuli (bai ji li), Radix Paeoniae Rubra (chi shao), and Herba Leonuri (yi mu cao). This preparation is traditionally indicated for “blood stasis” and “liver-kidney deficiency” patterns and is thought to promote microcirculation and melanocyte migration. A 2022 multicenter observational study noted modest improvement in segmental vitiligo after 6 months of treatment, particularly in facial lesions—but no placebo-controlled data are available to confirm efficacy independent of spontaneous repigmentation or concomitant therapies.
Topical herbal preparations also feature prominently in clinical practice. Bu Gu Zhi Jiu (Psoralea tincture), prepared from ethanol extracts of Psoralea corylifolia, is frequently applied before sun exposure or phototherapy. Its active compound, psoralen, acts as a photosensitizer that enhances UVA-induced melanogenesis—though it carries risks of phytophotodermatitis, blistering, and increased photocarcinogenic potential if not carefully dosed and monitored.
It is critical to emphasize that none of these TCM formulations are approved by major regulatory agencies—including the U.S. FDA, EMA, or WHO—for the treatment of vitiligo. Safety concerns persist: hepatotoxicity has been reported with prolonged use of Rehmannia-containing formulas; adulteration with undisclosed corticosteroids or heavy metals remains a documented risk in unregulated products; and herb–drug interactions—particularly with immunosuppressants or anticoagulants—are poorly characterized. Patients considering TCM interventions should do so only under the supervision of a qualified integrative dermatologist or TCM physician trained in Western medicine, with full disclosure to their primary care provider and ongoing monitoring of liver enzymes, complete blood count, and disease progression.